Rockwell Medical
Market Cap
US$132.9m
Last Updated
2021/01/24 00:21 UTC
Data Sources
Company Financials +
Executive Summary
Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. More Details
Rewards
Risk Analysis
Currently unprofitable and not forecast to become profitable over the next 3 years
Snowflake Analysis
Adequate balance sheet with limited growth.
Similar Companies
Share Price & News
How has Rockwell Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: RMTI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: RMTI's weekly volatility has decreased from 14% to 8% over the past year.
Market Performance
7 Day Return
18.3%
RMTI
0.5%
US Medical Equipment
2.3%
US Market
1 Year Return
-44.7%
RMTI
20.7%
US Medical Equipment
23.8%
US Market
Return vs Industry: RMTI underperformed the US Medical Equipment industry which returned 20.7% over the past year.
Return vs Market: RMTI underperformed the US Market which returned 23.8% over the past year.
Shareholder returns
| RMTI | Industry | Market | |
|---|---|---|---|
| 7 Day | 18.3% | 0.5% | 2.3% |
| 30 Day | 40.6% | 3.5% | 4.8% |
| 90 Day | 47.9% | 7.2% | 14.5% |
| 1 Year | -44.7%-44.7% | 21.7%20.7% | 26.6%23.8% |
| 3 Year | -74.7%-74.7% | 64.7%60.6% | 45.0%35.4% |
| 5 Year | -77.3%-77.3% | 166.9%147.1% | 126.2%101.0% |
Long-Term Price Volatility Vs. Market
How volatile is Rockwell Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall St
How Many Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Do Institutions Own?1 month ago | Simply Wall St
This Insider Has Just Sold Shares In Rockwell Medical, Inc. (NASDAQ:RMTI)2 months ago | Simply Wall St
Earnings Release: Here's Why Analysts Cut Their Rockwell Medical, Inc. (NASDAQ:RMTI) Price Target To US$7.00Valuation
Is Rockwell Medical undervalued compared to its fair value and its price relative to the market?
3.16x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate RMTI's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate RMTI's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: RMTI is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: RMTI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate RMTI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: RMTI is good value based on its PB Ratio (3.2x) compared to the US Medical Equipment industry average (5.7x).
Next Steps
Future Growth
How is Rockwell Medical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
89.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RMTI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RMTI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RMTI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RMTI's revenue (23.2% per year) is forecast to grow faster than the US market (10.6% per year).
High Growth Revenue: RMTI's revenue (23.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RMTI's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Rockwell Medical performed over the past 5 years?
-16.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RMTI is currently unprofitable.
Growing Profit Margin: RMTI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: RMTI is unprofitable, and losses have increased over the past 5 years at a rate of 16.4% per year.
Accelerating Growth: Unable to compare RMTI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RMTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.3%).
Return on Equity
High ROE: RMTI has a negative Return on Equity (-70.18%), as it is currently unprofitable.
Next Steps
Financial Health
How is Rockwell Medical's financial position?
Financial Position Analysis
Short Term Liabilities: RMTI's short term assets ($77.9M) exceed its short term liabilities ($12.7M).
Long Term Liabilities: RMTI's short term assets ($77.9M) exceed its long term liabilities ($30.5M).
Debt to Equity History and Analysis
Debt Level: RMTI's debt to equity ratio (49.6%) is considered high.
Reducing Debt: Insufficient data to determine if RMTI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RMTI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: RMTI has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 26.7% each year.
Next Steps
Dividend
What is Rockwell Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate RMTI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RMTI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if RMTI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RMTI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of RMTI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.6yrs
Average management tenure
CEO
Russell Ellison (72 yo)
0.75
Tenure
Dr. Russell H. Ellison, M.D., M.Sc., serves as President and Chief Executive Officer at Rockwell Medical, Inc. since April 17, 2020 and serves as its Director since January 09, 2020. He served as a consult...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer & Member of Scientific Advisory Board | 15.17yrs | US$736.73k | 0.60% $ 800.0k | |
| President | 0.75yr | no data | 0.0021% $ 2.8k | |
| Executive VP | 0.33yr | no data | no data | |
| Vice President of Operations | 2.08yrs | no data | no data | |
| VP, Corporate Controller & Principal Accounting Officer | 1.58yrs | no data | no data | |
| General Counsel | no data | no data | no data | |
| Senior Vice President of Business & Corporate Development | 2.33yrs | no data | no data | |
| Vice President of Sales and Strategic Accounts | 2.25yrs | no data | no data | |
| Vice President of Marketing | 1yr | no data | no data | |
| Chief Development Officer | 8.75yrs | US$965.87k | 0.35% $ 463.9k | |
| Secretary | 1.58yrs | no data | 0.0035% $ 4.6k | |
| Chief Medical Officer | 1.17yrs | no data | no data |
1.6yrs
Average Tenure
61yo
Average Age
Experienced Management: RMTI's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer & Member of Scientific Advisory Board | 15.17yrs | US$736.73k | 0.60% $ 800.0k | |
| President | 0.75yr | no data | 0.0021% $ 2.8k | |
| Independent Director | 3.33yrs | US$288.43k | 0.021% $ 28.2k | |
| Independent Chairman | 1.25yrs | US$119.73k | no data | |
| Member of Medical Advisory Board | 15.17yrs | no data | no data | |
| Member of Scientific Advisory Board | 15.17yrs | no data | no data | |
| Member of Scientific Advisory Board | 10.42yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.75yrs | no data | no data | |
| Member of Scientific Advisory Board | 8yrs | no data | no data | |
| Independent Director | 3.58yrs | US$197.93k | 0.45% $ 593.1k | |
| Member of Scientific Advisory Board | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | 5yrs | no data | no data |
6.5yrs
Average Tenure
67yo
Average Age
Experienced Board: RMTI's board of directors are considered experienced (6.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: RMTI insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.3%.
Top Shareholders
Company Information
Rockwell Medical, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Rockwell Medical, Inc.
- Ticker: RMTI
- Exchange: NasdaqGM
- Founded: 1994
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$132.874m
- Shares outstanding: 93.57m
- Website: https://www.rockwellmed.com
Number of Employees
Location
- Rockwell Medical, Inc.
- 411 Hackensack Avenue
- Suite 501
- Hackensack
- New Jersey
- 7601
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| RMTI | NasdaqGM (Nasdaq Global Market) | Yes | Common Shares | US | USD | Jan 1998 |
| RWM | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Jan 1998 |
Biography
Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialy...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/24 00:21 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.